Patent · US Active

Compositions of oral alkaline salts and metabolic acid inducers and uses thereof

US11324774B2 · kind B2 · utility

0Cited by
39References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 2, 2019
Grant dateMay 10, 2022
Priority date
Expiry dateJan 2, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0095
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions of alkaline salts and metabolic acid inducers and methods of use thereof are provided. The disclosed compositions may be used for stimulating vagal nerve efferent pathways, treating or preventing an inflammatory response or an autoimmune disorder, inhibiting or reducing one or more inflammatory M1 macrophages and/or one or more inflammatory neutrophils in the blood, promoting polarization of macrophages from a pro-inflammatory M1 state to an anti-inflammatory M2 state, and treating or preventing cardiovascular disease or metabolic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.